• Triamcinolone B1859: Practical Research Protocol

  2026-08-13

  Triamcinolone B1859 is a synthetic glucocorticoid agonist for controlled studies of glucocorticoid signaling, inflammation, and immunosuppression. This guide addresses stock preparation, assay controls, storage, and troubleshooting; the compound is for scientific research only and should not be used for diagnostic or clinical applications.

• MEG3, TGF-β, and NiO NP Pulmonary Fibrosis

  2026-08-13

  The reference study identifies lncRNA MEG3 as a regulatory brake on nickel oxide nanoparticle-induced pulmonary fibrosis. Using rat and A549 cell models, it links MEG3 loss to TGF-β1-dependent PI3K/AKT activation and collagen accumulation, while pharmacologic inhibition and MEG3 overexpression provide complementary pathway evidence.

• Ciclesonide Workflows for Airway Inflammation Research

  2026-08-12

  Build more informative airway assays by separating Ciclesonide activation from desisobutyryl-ciclesonide activity, while controlling formulation, exposure, and metabolite timing. The workflow also shows how findings from ERAD-targeted degradation can inform assay design without overstating an unproven connection.

• Cisplatin and Cancer Stemness: A Translational Playbook

  2026-08-12

  Cisplatin remains a powerful benchmark for DNA damage and apoptosis, but its translational value increases when researchers ask which tumor cell states survive treatment. This article connects CDDP mechanism with the KLF7–ITGA2 stemness axis in oral cancer and outlines a practical framework for resistance-focused validation.

• Trelagliptin and PI-3K/AKT Signaling in Adipocytes

  2026-08-11

  The reference study identifies a cellular mechanism by which trelagliptin succinate may improve insulin resistance in differentiated 3T3-L1 adipocytes. Its integrated analysis connects adipokine changes with IRS-1/AKT phosphorylation, GLUT4 membrane localization, and glucose uptake, while also defining important limits for translating the findings beyond the cell model.

• Budesonide and Lung Permeability Modeling

  2026-08-10

  Budesonide is more than a familiar anti-inflammatory corticosteroid: it is a strategic probe for connecting glucocorticoid pharmacology with biomimetic lung permeability workflows. This article translates recent IAM-LC and OT-CEC-MS findings into practical guidance for asthma inflammation models and respiratory disease research.

• EGCG Nanoparticles Enhance FLASH Radiotherapy

  2026-08-09

  The reference study reports that functionalized, self-assembled EGCG nanoparticles, termed BENPs, can sensitize tumor cells to FLASH-RT by increasing oxidative stress and DNA damage while also strengthening antitumor immune responses. Its combined cellular, animal, immunological, and transcriptomic design provides a useful framework for studying how radiosensitization may improve the therapeutic performance of ultra-high dose rate radiotherapy.

• MOB1A/B Loss Disrupts Intestinal Epithelial Homeostasis

  2026-08-08

  Bae et al. showed that intestinal epithelial depletion of MOB1A/B produces a paradoxical state of epithelial hyperproliferation alongside stem-cell loss, defective secretory differentiation, and progressive tissue degeneration. Their inhibitor-rescue experiments connect Hippo pathway disruption to reduced Wnt activity and excessive BMP/TGF-β signaling, clarifying how these pathways jointly maintain intestinal homeostasis.

• ARCA Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-08-07

  ARCA Cy5 EGFP mRNA (5-moUTP) combines direct Cy5 tracking of delivered RNA with EGFP-based confirmation of translation. This dual readout helps researchers distinguish uptake, intracellular trafficking, endosomal escape, and productive expression when screening mammalian-cell transfection reagents or biodegradable mRNA carriers.

• Nirmatrelvir (PF-07321332): Experimental Workflows for SARS-

  2026-08-07

  Nirmatrelvir (PF-07321332) stands out as a precision tool for dissecting SARS-CoV-2 replication dynamics and accelerating antiviral therapeutics research. This guide translates recent molecular findings into actionable protocols, troubleshooting strategies, and comparative assay frameworks for maximizing experimental reliability in coronavirus infection models.

• Sodium Salicylate and NF-κB Inhibition: Shaping Tumor Microe

  2026-08-06

  Explore how sodium salicylate, a potent NF-κB inhibitor, advances translational research by modulating inflammation and stroma in the tumor microenvironment. This article bridges mechanistic insight with strategic guidance, highlighting emerging nanomedicine approaches in pancreatic cancer and actionable protocols for researchers.

• Probenecid and Immunometabolic Flexibility: Advanced Insight

  2026-08-06

  Explore how Probenecid, a potent multidrug resistance modulator, intersects with immunometabolic signaling and neuroprotection. This in-depth article unveils novel mechanistic links and practical assay guidance beyond standard transporter inhibition.

• Ginsenoside Rg1: Neuroimmune Modulation and Research Benchma

  2026-08-05

  Ginsenoside Rg1, a triterpene saponin from Panax species, demonstrates robust neuroprotective and anti-inflammatory effects in preclinical models of anesthesia-induced neuroimmune disruption. It modulates regulatory T cells and restores gut-immune-brain axis integrity. High-purity Ginsenoside Rg1 from APExBIO enables reproducible neuroprotection and apoptosis research.

• Ciclesonide: Empowering Advanced Respiratory and ERAD Resear

  2026-08-05

  Ciclesonide's unique prodrug activation and potent glucocorticoid receptor binding make it a standout tool in both respiratory disease modeling and next-generation targeted protein degradation workflows. Integrating ERAD-hijacking strategies, it enables researchers to address longstanding barriers in transmembrane protein research.

• Canagliflozin (hemihydrate): Reliable SGLT2 Inhibitor for La

  2026-08-04

  This article addresses real-world challenges in cell viability and metabolic pathway assays, providing evidence-driven guidance for deploying Canagliflozin (hemihydrate) (SKU C6434). It emphasizes the compound’s workflow reliability, mechanistic specificity, and QC-backed reproducibility, helping researchers optimize protocols for glucose metabolism and diabetes mellitus research.

450 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page